Usability of Levodopa Cyclops ® Compared to INBRIJA ® During an off Episode in Parkinson’s Disease Patients

Journal of Aerosol Medicine and Pulmonary Drug Delivery · Published 2026-06-23 · DOI 10.1177/19412711261456530

Free full text

Authors (6)

Valesca Wangsawirana, Lara de Jong, Annebet van der Meulen, Paul Hagedoorn, Marianne Luinstra, Henderik Willem Frijlink

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Wangsawirana, V., Jong, L., Meulen, A., et al. (2026). Usability of Levodopa Cyclops ® Compared to INBRIJA ® During an off Episode in Parkinson’s Disease Patients. Journal of Aerosol Medicine and Pulmonary Drug Delivery. https://doi.org/10.1177/19412711261456530

Related articles

• Letter: Respiratory Effectiveness Group Position Statement: Inhaler Choice: Balancing Personalized Health Care and Environmental Responsibility · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2025 · Same journal
• Inhaled Volume as a Digital Biomarker Predicting Outcomes in Chronic Respiratory Disease · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2025 · Same journal
• Effect of Inspiratory Muscle Training on Aerosol Deposition and Pulmonary Perfusion in Post-COVID-19 Syndrome: A Gamma Scintigraphy Study · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2026 · Same journal
• Prospects of Inhalable Formulations of Conventionally Administered Repurposed Drugs for Adjunctive Treatment of Drug-Resistant Tuberculosis: Supporting Evidence from Clinical Trials and Cohort Studies · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2024 · Same journal
• Comparative Efficacy of Two Inhalational Techniques when Using a Pressurized Meter Dose Inhaler with Valved Holding Chamber in Children with Asthma: A Randomized Controlled Trial · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2026 · Same journal
• Lung Deposition of Extrafine Versus Nonextrafine Aerosols at Low Inhalation Flow Rates in Adult Asthma Patients: A Composition Study · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2025 · Same journal
• Multi-Participant Blinded Investigation into Internal Losses of Medication in Commercially Available Mixing Inlets: Testing Different Orally Inhaled Product Classes Following Pharmacopeial Methods · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2025 · Same journal
• Safety and Pharmacokinetic Data for Inhaled Administration of Nintedanib Dry Powder Inhalation for Treatment of Pulmonary Fibrotic Diseases · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2026 · Same journal
• Effect of Replacing Inhalation Devices on Medication Adherence · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2026 · Same journal
• Scale-Up and Postapproval Changes in Orally Inhaled Drug Products: Scientific and Regulatory Considerations · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2024 · Same journal